Business Description
Conmed Corp
NAICS : 334510
SIC : 3845
ISIN : US2074101013
Share Class Description:
CNMD: Ordinary SharesDescription
Conmed Corp is a Utica, New York-based medical equipment company that focuses on sports medicine procedures and general surgery. The firm currently reports through two reporting units, orthopedic surgery, and general surgery. From a geographic perspective, the firm is U.S.-centric, with maximum domestic sales accounting for revenue, EMEA accounting for second place, APAC at third, and the non-U.S. Americas region driving the remaining revenue.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.03 | |||||
| Equity-to-Asset | 0.34 | |||||
| Debt-to-Equity | 1.33 | |||||
| Debt-to-EBITDA | 7.73 | |||||
| Interest Coverage | 1.65 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 2.17 | |||||
| Beneish M-Score | -2.23 | |||||
| WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 2.4 | |||||
| 3-Year EBITDA Growth Rate | -43 | |||||
| 3-Year FCF Growth Rate | -46.7 | |||||
| 3-Year Book Growth Rate | -0.7 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 42.16 | |||||
| 9-Day RSI | 37.87 | |||||
| 14-Day RSI | 36.96 | |||||
| 6-1 Month Momentum % | 10.16 | |||||
| 12-1 Month Momentum % | 34.48 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.74 | |||||
| Quick Ratio | 0.82 | |||||
| Cash Ratio | 0.08 | |||||
| Days Inventory | 219.11 | |||||
| Days Sales Outstanding | 66.21 | |||||
| Days Payable | 51.95 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.79 | |||||
| Dividend Payout Ratio | 0.27 | |||||
| Forward Dividend Yield % | 0.79 | |||||
| 5-Year Yield-on-Cost % | 0.78 | |||||
| 3-Year Average Share Buyback Ratio | -2.4 | |||||
| Shareholder Yield % | -5.99 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 53.51 | |||||
| Operating Margin % | 5.55 | |||||
| Net Margin % | 7.75 | |||||
| ROE % | 12.04 | |||||
| ROA % | 3.9 | |||||
| ROIC % | 10.37 | |||||
| ROC (Joel Greenblatt) % | 14.44 | |||||
| ROCE % | 3.19 | |||||
| Years of Profitability over Past 10-Year | 9 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 35.64 | |||||
| PE Ratio without NRI | 35.64 | |||||
| Shiller PE Ratio | 104.67 | |||||
| PS Ratio | 2.76 | |||||
| PB Ratio | 3.97 | |||||
| Price-to-Free-Cash-Flow | 207.51 | |||||
| Price-to-Operating-Cash-Flow | 86.34 | |||||
| EV-to-EBIT | 65.01 | |||||
| EV-to-Forward-EBIT | 24.24 | |||||
| EV-to-EBITDA | 30.55 | |||||
| EV-to-Forward-EBITDA | 16.5 | |||||
| EV-to-Revenue | 3.61 | |||||
| EV-to-Forward-Revenue | 3.66 | |||||
| EV-to-FCF | 257.87 | |||||
| Price-to-Projected-FCF | 2.78 | |||||
| Price-to-Median-PS-Value | 1.23 | |||||
| Earnings Yield (Greenblatt) % | 1.54 | |||||
| Forward Rate of Return (Yacktman) % | -19.31 |
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NYSE:CNMD
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Conmed Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 1,139.075 | ||
| EPS (TTM) ($) | 2.83 | ||
| Beta | 1.2 | ||
| Volatility % | 32.95 | ||
| 14-Day RSI | 36.96 | ||
| 14-Day ATR ($) | 2.728528 | ||
| 20-Day SMA ($) | 105.3345 | ||
| 12-1 Month Momentum % | 34.48 | ||
| 52-Week Range ($) | 71.09 - 138.47 | ||
| Shares Outstanding (Mil) | 30.74 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Conmed Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Conmed Corp Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Conmed Corp Frequently Asked Questions
What is Conmed Corp(CNMD)'s stock price today?
The current price of CNMD is $100.85. The 52 week high of CNMD is $138.47 and 52 week low is $71.09.
When is next earnings date of Conmed Corp(CNMD)?
The next earnings date of Conmed Corp(CNMD) is 2023-10-26 Est..
Does Conmed Corp(CNMD) pay dividends? If so, how much?
The Dividend Yield %  of Conmed Corp(CNMD) is 0.79% (As of Today), Highest Dividend Payout Ratio of Conmed Corp(CNMD) was 2.5. The lowest was 0.27. And the median was 0.69. The  Forward Dividend Yield % of Conmed Corp(CNMD) is 0.79%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers